Respira: Hypersensitivity to any of the ingredients, cardiovascular disease, hyperthyroidism, pregnancy and lactation, patients with acute porphyria.
Respira-D: Sensitivity or intolerance to any of the ingredients.
Patients being treated with monoamine oxidase inhibitors or within 14 days of stopping such treatment.
Should not be used in patients with hyperthyroidism; cardiovascular disease eg, ischaemic heart disease, arrhythmia or tachycardia; occlusive vascular disorders, including arteriosclerosis, hypertension or aneurysms; diabetes mellitus; closed-angle glaucoma.
Use in children: Should not be administered to children <1 year.